Evidence map›Paper›PMID 26290394›Full record

ArticleCancer prevention research (Philadelphia, Pa.)2015

Targeted DNA Methylation Screen in the Mouse Mammary Genome Reveals a Parity-Induced Hypermethylation of Igf1r That Persists Long after Parturition.

Tiffany A Katz, Serena G Liao, Vincent J Palmieri, Robert K Dearth, Thushangi N Pathiraja, Zhiguang Huo, Patricia Shaw, Sarah Small, Nancy E Davidson, David G Peters and 3 more

Open access · greenAbstract read
In one paragraph

Article in Cancer prevention research (Philadelphia, Pa.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. FOXA1 Protein Expression in ERCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2020
    Article
  8. Article
  9. Pregnancy duration and breast cancer risk.Nature communications · 2018
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Tiffany A KatzDepartment of Pharmacology and Chemical Biology, Women's Cancer Research Center, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania.
Serena G LiaoDepartment of Biostatistics, University of Pittsburgh, Pittsburgh, Pennsylvania.
Vincent J PalmieriDepartment of Pharmacology and Chemical Biology, Women's Cancer Research Center, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania.
Robert K DearthDepartment of Biology, University of Texas-Rio Grande Valley, Edinburg, Texas.
Thushangi N PathirajaCancer Therapeutics and Stratified Oncology, Genome Institute of Singapore, Singapore.
Zhiguang HuoDepartment of Biostatistics, University of Pittsburgh, Pittsburgh, Pennsylvania.
Patricia ShawDepartment of Obstetrics. Gynecology, and Reproductive Sciences, University of Pittsburgh, Pennsylvania.
Sarah SmallDepartment of Pharmacology and Chemical Biology, Women's Cancer Research Center, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania.
Nancy E DavidsonDepartment of Pharmacology and Chemical Biology, Women's Cancer Research Center, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania.
David G PetersDepartment of Obstetrics. Gynecology, and Reproductive Sciences, University of Pittsburgh, Pennsylvania.
George C TsengDepartment of Biostatistics, University of Pittsburgh, Pittsburgh, Pennsylvania.
Steffi OesterreichDepartment of Pharmacology and Chemical Biology, Women's Cancer Research Center, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania. leeav@upmc.edu oesterreichs@upmc.edu.
Adrian V LeeDepartment of Pharmacology and Chemical Biology, Women's Cancer Research Center, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania. leeav@upmc.edu oesterreichs@upmc.edu.
UPMC Hillman Cancer Center · USUniversity of Pittsburgh · USGenome Institute of Singapore · SGThe University of Texas Rio Grande Valley · US

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JOHN C. BYRD · 1988 to 2026
$158.0M
IRS1 and 2 Signaling in Mammary Development and CancerR01CA094118 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LEE, ADRIAN V · 2002 to 2015
$3.0M
Translational Research Training in Cancer Prevention and ControlT32CA186873 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Kathryn H. Schmitz, Jian-Min Yuan · 2014 to 2026
$2.7M
NCI NIH HHS P30 CA047904NCI NIH HHS P30CA047904NCI NIH HHS R01 CA094118NCI NIH HHS R01CA94118NCI NIH HHS T32 CA186873NCI NIH HHS T32CA186873
6 · The paper itself

Abstract

The most effective natural prevention against breast cancer is an early first full-term pregnancy. Understanding how the protective effect is elicited will inform the development of new prevention strategies. To better understand the role of epigenetics in long-term protection, we investigated parity-induced DNA methylation in the mammary gland. FVB mice were bred or remained nulliparous and mammary glands harvested immediately after involution (early) or 6.5 months following involution (late), allowing identification of both transient and persistent changes. Targeted DNA methylation (109 Mb of Ensemble regulatory features) analysis was performed using the SureSelectXT Mouse Methyl-seq assay and massively parallel sequencing. Two hundred sixty-nine genes were hypermethylated and 128 hypomethylated persistently at both the early and late time points. Pathway analysis of the persistently differentially methylated genes revealed Igf1r to be central to one of the top identified signaling networks, and Igf1r itself was one of the most significantly hypermethylated genes. Hypermethylation of Igf1r in the parous mammary gland was associated with a reduction of Igf1r mRNA expression. These data suggest that the IGF pathway is regulated at multiple levels during pregnancy and that its modification might be critical in the protective role of pregnancy. This supports the approach of lowering IGF action for prevention of breast cancer, a concept that is currently being tested clinically.

Indexed as

AnimalsBreast NeoplasmsDNA MethylationFemaleGenomeMammary Glands, AnimalMiceParityParturitionPolymerase Chain ReactionPregnancyReceptor, IGF Type 1Receptor, IGF Type 1

Identifiers

PMID26290394
PMCPMC4677681
OpenAlexW2139110498

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.